CELECOXIB 50 MG CAPSULE
For 30 capsules
Pharmacies pay
$2.74 filed
30 × $0.09139 per EA
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D paid
$13.32 filed
30 × $0.44411 per EA, Part D average
Medicare's price is not your price.
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
The spread
4.9× estimated
Medicare paid 4.9× what pharmacies pay.
Part D averages every strength and form sold under “Celecoxib” into one figure, so it is not specific to this NDC.
OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)
Cost-plus estimate
$8.15 estimated
$2.74 + $0.41 (15%) + $5.00 fee per fill = $8.15
This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out
OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)
Open the interactive card Change the quantity, type what you were charged, and see every record in full.
What it is
CELECOXIB 50 MG CAPSULE is how the CMS NADAC file names this product. The FDA NDC Directory lists it as celecoxib.
FDA gives its dosage form as capsule and its route as oral.
FDA lists 13 labelers (the companies named on the label) for its NDCs, among them Actavis Pharma, Inc., AiPing Pharmaceutical, Inc. and NorthStar RxLLC.
FDA’s Established Pharmacologic Class for it is Nonsteroidal Anti-inflammatory Drug.
The NADAC file of 2026-10-14 prices it under 13 NDCs (National Drug Codes).
NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.
What pharmacies pay
Pharmacies pay $2.74 for 30 capsules (30 × $0.09139 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.
NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.
What NADAC measures · Why 30 capsules · NADAC explanation codes
The 13 labelers
| Labeler | NDCs | Pharmacies pay per unit |
|---|---|---|
| Actavis Pharma, Inc. | 1 | $0.09139 per EA filed |
| AiPing Pharmaceutical, Inc. | 1 | $0.09139 per EA filed |
| Alembic Pharmaceuticals Inc. | 1 | $0.09139 per EA filed |
| Aurobindo Pharma Limited | 1 | $0.09139 per EA filed |
| Cipla USA Inc. | 1 | $0.09139 per EA filed |
| Cranbury Pharmaceuticals, LLC | 1 | $0.09139 per EA filed |
| Lupin Pharmaceuticals, Inc. | 1 | $0.09139 per EA filed |
| Macleods Pharmaceuticals Limited | 1 | $0.09139 per EA filed |
| Micro Labs Limited | 1 | $0.09139 per EA filed |
| Modavar Pharmaceuticals LLC | 1 | $0.09139 per EA filed |
| Mullan Pharmaceutical Inc. | 1 | $0.09139 per EA filed |
| NorthStar RxLLC | 1 | $0.09139 per EA filed |
| ScieGen Pharmaceuticals, Inc. | 1 | $0.09139 per EA filed |
All 13 NDCs, with labeler and price
- 00591-3982-60 · Actavis Pharma, Inc. · $0.09139 per EA · eff. 2026-09-23 filed
- 11788-0112-60 · AiPing Pharmaceutical, Inc. · $0.09139 per EA · eff. 2026-09-23 filed
- 16714-0731-01 · NorthStar RxLLC · $0.09139 per EA · eff. 2026-09-23 filed
- 27808-0295-01 · Cranbury Pharmaceuticals, LLC · $0.09139 per EA · eff. 2026-09-23 filed
- 33342-0155-09 · Macleods Pharmaceuticals Limited · $0.09139 per EA · eff. 2026-09-23 filed
- 42571-0142-60 · Micro Labs Limited · $0.09139 per EA · eff. 2026-09-23 filed
- 50228-0156-60 · ScieGen Pharmaceuticals, Inc. · $0.09139 per EA · eff. 2026-09-23 filed
- 62332-0140-60 · Alembic Pharmaceuticals Inc. · $0.09139 per EA · eff. 2026-09-23 filed
- 65862-0907-60 · Aurobindo Pharma Limited · $0.09139 per EA · eff. 2026-09-23 filed
- 68180-0395-07 · Lupin Pharmaceuticals, Inc. · $0.09139 per EA · eff. 2026-09-23 filed
- 69097-0423-03 · Cipla USA Inc. · $0.09139 per EA · eff. 2026-09-23 filed
- 72241-0022-03 · Modavar Pharmaceuticals LLC · $0.09139 per EA · eff. 2026-09-23 filed
- 83301-0028-01 · Mullan Pharmaceutical Inc. · $0.09139 per EA · eff. 2026-09-23 filed
Other strengths, forms and brands
7 other products in the NADAC file share the FDA nonproprietary name celecoxib with CELECOXIB 50 MG CAPSULE.
| Product | Pharmacies pay per unit | Medicare per unit |
|---|---|---|
| CELEBREX 100 MG CAPSULE | $9.53398 per EA filed | $14.38818 per EA filed |
| CELEBREX 200 MG CAPSULE | $15.64674 per EA filed | $14.38818 per EA filed |
| CELEBREX 400 MG CAPSULE | $23.49717 per EA filed | $14.38818 per EA filed |
| CELECOXIB 50 MG CAPSULE this page | $0.09139 per EA filed | $0.44411 per EA filed |
| CELECOXIB 100 MG CAPSULE | $0.0614 per EA filed | $0.44411 per EA filed |
| CELECOXIB 200 MG CAPSULE | $0.07623 per EA filed | $0.44411 per EA filed |
| CELECOXIB 400 MG CAPSULE | $0.24804 per EA filed | $0.44411 per EA filed |
| ELYXYB 120 MG/4.8 ML SOLUTION | $30.53807 per ML filed | $29.54115 per ML filed |
Part D is one average per brand and generic name, over every strength and form.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17
Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18
Compared with its class
The middle of its 13 NDCs’ NADAC prices is $0.09139 per EA filed.
Of the 154 other products in FDA’s Nonsteroidal Anti-inflammatory Drug class priced per EA, 79 have a higher middle NADAC price and 75 a lower one. The one in the middle is ACETAMINOPHEN-IBUPROFEN 250-125 MG TABLET, at $0.10711 per EA filed (eff. 2026-10-07).
Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.
CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23, 2026-10-07 · as of 2026-10-14 · retrieved 2026-10-17
What Medicare paid
Medicare Part D paid $13.32 for 30 capsules, at an average of $0.44411 per EA in 2024 (2024-01-01 to 2024-12-31) for “Celecoxib”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).
That average covers 5,701,064 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.
Medicare's price is not your price.
What Part D spending measures · Which Medicare figure OpenBill compares · How the spread is worked out
What to ask at the counter
None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.
- What is your cash price for 30 capsules? Is it lower than what I would pay through my insurance?
- If you have Medicare Part D: what is my plan’s copay or coinsurance for it? The Part D average on this page is not what you pay.
- These are questions about price, not medical advice. Do not change or stop a medicine without talking to your prescriber or pharmacist.
Questions
- Why is the comparison with Medicare for CELECOXIB 50 MG CAPSULE labelled estimated?
- Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Celecoxib / Celecoxib: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.
Related pages
Its pharmacologic class
Related in the same class
- IBUPROFEN 400 MG TABLET
- NABUMETONE 500 MG TABLET
- DICLOFENAC POT 25 MG TABLET
- INDOMETHACIN 25 MG CAPSULE
- ETODOLAC 200 MG CAPSULE